|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00557 TIANYUAN HEALTH
Nominal 
0.475 -0.005 (-1.042%) | 2025/12 - Final HKD(K$) | %Chg (Compare to Final) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | |
| Turnover | 19,178 | -28.560% | 26,845 | 45,230 | 54,216 | 94,588 |
| Cost of Sales | (2,939) | -47.583% | (5,607) | (17,285) | (19,391) | (23,281) |
| Gross Profit | 16,239 | -23.538% | 21,238 | 27,945 | 34,825 | 71,307 |
| 2025/12 - Final HKD(K$) | %Chg (Compare to Final) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (27,248) | 16.082% | (23,473) | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | 2,744 | 9.892% | 2,497 | (10,013) | (800) | 1,299 | |
| Share of Results of Asso. & JCEs | (311) | 2121.429% | (14) | (365) | 242 | 184 | |
| Profit / (Loss) before Taxation | (39,066) | 1.658% | (38,429) | (28,778) | (40,349) | (19,063) | |
| Taxation | 650 | -- | (177) | 1,821 | 0 | 0 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 4,402 | 0.778% | 4,368 | 11,473 | 11,313 | 2,209 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (34,014) | -0.654% | (34,238) | (15,484) | (29,036) | (16,854) | |
| 2025/12 - Final HKD(K$) | %Chg (Compare to Final) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | |
| Net Finance Costs / (Income) | 2,380 | -3.994% | 2,479 | 3,391 | 3,931 | 4,480 |
| Depreciation & Amortisation | 8,572 | 7.432% | 7,979 | 9,076 | 9,529 | 11,869 |
| Directors' Emoluments | 1,051 | 0.191% | 1,049 | 1,094 | 5,639 | 9,012 |
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | -8.520 | -0.699% | -8.580 | -3.880 | -7.280 | -4.220 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 0.027 | 0.013 | (0.076) | 0.041 |
| NBV per share ($) | 0.404 | -- | 0.488 | 0.577 | 0.562 | 0.642 |
| Remarks: | Real time quote last updated: 01/04/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD -34,014 |
| %Change | -0.654% |
| EPS / (LPS) | HKD -0.085 |
| NBV Per Share ($) | HKD 0.404 |